Answers are grounded in this paper and cite their sources.
Vascular smooth muscle cell remodeling contributes to neointimal hyperplasia after vascular injury. We examined ferroptosis-associated transcriptional observations and selected candidate markers in rat carotid injury datasets and tissue specimens. We examined day-28 single-cell data (GSE174098), day-14 bulk data (GSE164050), and day-14 tissue observations from three paired rats. Reported scores, pathway enrichment, ligand-receptor inference, exploratory feature rankings, and candidate-gene expression were reviewed alongside immunohistochemistry and transmission electron microscopy. Retained scripts and the available processed count object were inspected; QC displays were revised without rerunning downstream analyses. The reported single-cell score was descriptively lower in the injured library, but QC metrics, scoring provenance, and the scored cell subset remain unverified. Bulk enrichment highlighted oxidative-stress and remodeling pathways. Reported bulk expression and tissue staining showed lower ATG13 and CDO1 and higher PLIN2 in injured arteries. Their independent algorithmic selection is not established. Mitochondrial morphology differed between conditions but did not establish ferroptotic death. These exploratory observations nominate ATG13, CDO1, and PLIN2 as candidate remodeling markers. They do not establish VSMC-specific gene action, ferroptotic death, or validated therapeutic targets. Small cohorts, different sampling times, and unresolved analytical provenance limit inference and require reanalysis and functional validation.
No takes yet. Share an insight, caveat, or question.
Ya et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: